Fantex Postpones Arian Foster Share Sale Because of Back Surgery
This article is for subscribers only.
Fantex, Inc. postponed plans to offer public shares on Arian Foster with the Houston Texans running back set to undergo season-ending back surgery.
San Francisco-based Fantex last month filed with the U.S. Securities and Exchange Commission to raise $10.6 million in an initial public offering priced at $10 a share for Foster, who pledged 20 percent of his on- and off-field earnings to the company in exchange for most of the proceeds of the IPO. It was to be the first public offering for a professional athlete.